Showing results (331-340 of 4,634) with videos related to
Sort By:
Pageof 464
Anti-Cancer Drugs|April 1, 1993
Antiproliferative and chemomodulatory effects of interferon-gamma on doxorubicin-sensitive and -resistant tumor cell linesN Borsellino, M Crescimanno, C Flandina, et al.Anti-Cancer Drugs|August 1, 1996
Correlation of the clinical response to chemotherapy in breast cancer with ex vivo chemosensitivityI A Cree, C M Kurbacher, M Untch, et al.Anti-Cancer Drugs|August 1, 1996
Molecular modeling of the interaction of anthracenyl-amino acid topoisomerase inhibitors with the DNA sequence d(CGTACG)J Cummings, J A Hadfield, I Meikle, et al.Anti-Cancer Drugs|August 1, 1996
Synthesis and evaluation of water-soluble polyethylene glycol-paclitaxel conjugate as a paclitaxel prodrugC Li, D Yu, T Inoue, et al.Anti-Cancer Drugs|August 1, 1996
Marked enhancement in vivo of paclitaxel's (taxol's) tumor-regressing activity by ATP-depleting modulationD S Martin, R L Stolfi, J R Colofiore, et al.Anti-Cancer Drugs|August 1, 1996
Association of docetaxel/paclitaxel with irradiation in ovarian carcinoma cell lines in bidimensional (sulforhodamine B assay) and tridimensional (spheroids) culturesG Griffon-Etienne, J L Merlin, C MarchalAnti-Cancer Drugs|August 1, 1996
Reversal of P-glycoprotein is greatly reduced by the presence of plasma but can be monitored by an ex vivo clinical assayS Ayesh, E Lyubimov, N Algour, et al.Anti-Cancer Drugs|August 1, 1996
Pharmacokinetic analysis of protein-conjugated doxorubicin (DXR) and its degraded adducts in DXR-sensitive and -resistant rat hepatoma cellsN Takahashi, T Asakura, K OhkawaAnti-Cancer Drugs|November 1, 1996
Camptothecin exhibits selective cytotoxicity towards human breast carcinoma as compared to normal bovine endothelial cells in vitroM K Clements, S Wasi, S S DaoudPageof 464